SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPPHE Hotel Group Limited Regulatory News (PPH)

Share Price Information for PPHE Hotel Group Limited (PPH)

Share Price is delayed by 15 minutes
Get Live Data
2,025.00    10.00 (0.50%)
Bid:
2,015.00
Ask:
2,030.00
Spread: 15.00 (0.744%)
Market Cap: £847.64m
PPH Live PriceLast checked at - London Stock Exchange

Intraday PPHE Hotel Group Limited Share Chart

Form 8.3 PPHE Hotel Group Ltd

17 Mar 2026 15:21

RNS Number : 0153X
Threadneedle Asset Mgmt Hldgs Ltd
17 March 2026
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Threadneedle Asset Management Holdings Ltd (on behalf of affiliate companies that carry on the business of fund and portfolio management)

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Ameriprise Financial, Inc. ultimate parent company of Threadneedle Asset Management Holdings Ltd and affiliated companies.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

PPHE Hotel Group Limited

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

16/03/2026

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/a

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

Ordinary NPV

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

434,363

1.04%

 

 

(2) Cash-settled derivatives:

 

(3) Stock-settled derivatives (including options) and agreements to Purchase/sell:

 

 

 

TOTAL:

434,363

1.04%

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

Ordinary NPV

Purchase

100

GBP 16.96

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

 

 

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

17/03/2026

Contact name:

Ben Lyon

Telephone number*:

01793 363754

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETEASDXFAEKEFA
Date   Source Headline
8th Jan 20247:00 amRNSAppointment of Advisor
27th Dec 20237:00 amRNSPDMR Notification
27th Dec 20237:00 amRNSHolding(s) in Company
27th Dec 20237:00 amRNSHolding(s) in Company
6th Dec 20237:00 amRNSAppointment of Non-Executive Deputy Chairman
27th Nov 20237:00 amRNSPlanning approval for new hotel in London
9th Nov 20237:00 amRNSMarch 2024 opening of art’otel London Hoxton
26th Oct 20237:00 amRNSPublication of Arena Q3 Interim Financial Report
26th Oct 20237:00 amRNSTrading Update
5th Oct 20237:00 amRNSNotice of Trading Update
27th Sep 20237:00 amRNSCapital returns policy and payment of dividend
12th Sep 20237:00 amRNSOctober opening of art’otel Zagreb
31st Aug 20237:00 amRNSInterim Results
15th Aug 20237:00 amRNSInterim Results Investor Presentation and Q&A
1st Aug 20237:00 amRNSNotice of Interim Results
27th Jul 20237:00 amRNSPublication of Arena Interim Financial Report
29th Jun 20237:00 amRNSPre-Close H1 Trading Update
6th Jun 20237:00 amRNSAnalyst Site Visit to Croatia
23rd May 20234:53 pmRNSResult of Annual General Meeting
15th May 20237:00 amRNSAcceleration of global growth of art’otel brand
11th May 20237:00 amRNSAppointment of Signature Artist at art'otel Hoxton
9th May 20237:00 amRNSRepositioning of art’otel Berlin Mitte
27th Apr 20237:00 amRNSPublication of Arena Q1 Trading Update
27th Apr 20237:00 amRNSTrading Update
25th Apr 20237:00 amRNSSecond hotel under PPHE/Radisson partnership
25th Apr 20237:00 amRNSApproval for European Hospitality Real Estate Fund
18th Apr 202311:22 amRNSNotice of Additional Resolution
11th Apr 20237:00 amRNSNotice of Trading Update
21st Mar 20237:00 amRNSAnnouncement of Posting of AGM Notice
14th Mar 20237:00 amRNSEuropean Hospitality Real Estate Fund
8th Mar 20237:00 amRNSTransaction in own securities
2nd Mar 20235:30 pmRNSPDMR purchase of shares in the Company
2nd Mar 20234:56 pmRNSGrant and exercise of EVP Annual Bonus Plan awards
2nd Mar 20237:00 amRNSAnnual Results & Publication of Annual Report
2nd Mar 20237:00 amRNSEuropean Hospitality Real Estate Fund
1st Mar 20237:00 amRNSTransaction in own securities
28th Feb 20233:07 pmRNSPublication of Arena Hospitality Annual Report
28th Feb 20237:00 amRNSTransaction in own securities
27th Feb 20237:00 amRNSTransaction in own securities
24th Feb 20237:00 amRNSTransaction in own securities
23rd Feb 20237:00 amRNSTransaction in own securities
22nd Feb 20237:00 amRNSTransaction in own securities
21st Feb 20237:00 amRNSTransaction in own securities
20th Feb 20237:00 amRNSTransaction in own securities
17th Feb 20237:00 amRNSAnnual Results investor presentation and Q&A
17th Feb 20237:00 amRNSTransaction in own securities
16th Feb 202312:24 pmRNSNotice of Annual Results
16th Feb 20237:00 amRNSTransaction in own securities
15th Feb 20237:00 amRNSTransaction in own securities
14th Feb 20237:00 amRNSTransaction in own securities

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.